This approval of shelf life extension is based on the availability of additional stability data, which Bharat Biotech submitted to Central Drugs Standard Control Organisation (CDSCO).
Bharat Biotech, the manufacturer of the indigenous Covid-19 vaccine Covaxin, on Wednesday said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of Covid-19 vaccine Covaxin up to 12 months from the date of manufacture.
"The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO," Bharat Biotech said in a tweet.
The shelf life extension has been communicated to "our stakeholders," it added.
(With PTI Inputs)